glp 1 and potassium DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner Frontiers | GLP-1 Receptor Agonists

The Phase 2 SHAPE trial (NCT04831281) in Parkinsons disease dementia and dementia with Lewy bodies failed its primary endpoint in December 2023

Read it here: To view or add a comment, sign in The USP has updated Chapter 60 'Microbiological Examination of Nonsterile Products - Tests for Burkholderia cepacia Complex', with clarifications designed to improve consistency and interpretation

Additionally, the effects of carnitine on kidney function and renal safety should be carefully evaluated, especially in individuals with pre-existing kidney disease or those taking certain medications

Fatty fish such as salmon, mackerel, and nuts and seeds provide essential fatty acids and antioxidants that keep your skin hydrated and reduce inflammation

In AD, mitochondrial abnormalities, including impaired electron transport chain function and reduced mitochondrial biogenesis, lead to increased ROS production and diminished ATP generation